Population Pharmacokinetic Model to Optimize Cefotaxime Dosing Regimen in Critically Ill Children

被引：0

作者：

Agathe Béranger

Mehdi Oualha

Saïk Urien

Mathieu Genuini

Sylvain Renolleau

Radia Aboura

Déborah Hirt

Claire Heilbronner

Julie Toubiana

Jean-Marc Tréluyer

Sihem Benaboud

机构：

[1] Université Paris Descartes,Unité de Recherche Clinique, Hôpital Cochin

[2] Sorbonne-Paris Cité,Necker

[3] Université Paris Descartes,EA7323, Evaluation des Thérapeutiques et Pharmacologie Périnatale et Pédiatrique

[4] Université Paris Descartes,Service de Réanimation et Surveillance Continue Médico

[5] Sorbonne-Paris Cité,Chirurgicales, Hôpital Necker Enfants

[6] Université Paris Descartes,Malades

[7] Sorbonne-Paris Cité,Service de Pharmacologie Clinique, Hôpital Cochin

[8] Université Paris Descartes,Service de Pédiatrie Générale, Equipe Mobile D’Infectiologie, Hôpital Necker

[9] Sorbonne-Paris Cité,Enfants Malades

来源：

Clinical Pharmacokinetics | 2018年 / 57卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

下载

页码：867 / 875

页数：8

共 50 条

[31] Pharmacokinetic-Pharmacodynamic- Model-Guided Doripenem Dosing in Critically Ill Patients
Samtani, Mahesh N.
Flamm, Robert
Kaniga, Kone
Nandy, Partha
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (06) : 2360 - 2364
[32] Development of a dosing algorithm for meropenem in critically ill patients based on a population pharmacokinetic/pharmacodynamic analysis
Ehmann, Lisa
Zoller, Michael
Minichmayr, Iris K.
Scharf, Christina
Huisinga, Wilhelm
Zander, Johannes
Kloft, Charlotte
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2019, 54 (03) : 309 - 317
[33] External Evaluation of Population Pharmacokinetic Models to Inform Precision Dosing of Meropenem in Critically Ill Patients
Yang, Nan
Wang, Jing
Xie, Yueliang
Ding, Junjie
Wu, Cuifang
Liu, Jingjing
Pei, Qi
FRONTIERS IN PHARMACOLOGY, 2022, 13
[34] Individualization of Piperacillin Dosing for Critically Ill Patients: Dosing Software To Optimize Antimicrobial Therapy
Felton, T. W.
Roberts, J. A.
Lodise, T. P.
Van Guilder, M.
Boselli, E.
Neely, M. N.
Hope, W. W.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (07) : 4094 - 4102
[35] External validation of pharmacokinetic population model of thiopental in critically ill patients
Marsot, A.
Goirand, F.
Milesi, N.
Dumas, M.
Boulamery, A.
Simon, N.
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2011, 25 : 90 - 90
[36] Dose optimization of cefotaxime as pre-emptive treatment in critically ill adult patients: A population pharmacokinetic study
Roelofsen, Eveline E.
Abdulla, Alan
Muller, Anouk E.
Endeman, Henrik
Gommers, Diederik
Dijkstra, Annemieke
Hunfeld, Nicole G. M.
de Winter, Brenda C. M.
Koch, Birgit C. P.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (02) : 705 - 713
[37] Using PK/PD to Optimize Antibiotic Dosing for Critically Ill Patients
Roberts, Jason A.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (12) : 2070 - 2079
[38] Pharmacokinetics of a novel dosing regimen of oral melatonin in critically ill patients
Bellapart, Judith
Roberts, Jason Alexander
Appadurai, Vinesh
Wallis, Steven C.
Nunez-Nunez, Maria
Boots, Robert James
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2016, 54 (03) : 467 - 472
[39] Treatment of hypophosphataemia in critically ill patients with a two day dosing regimen
LJ Giles
A Jennings
B Ng
G Creed
L Gallard
D Pierre
R Beale
A McLuckie
Critical Care, 4 (Suppl 1):
[40] Parametric and nonparametric population pharmacokinetic analysis of fluconazole in critically ill patients and dosing simulations for Candida infections
Matusik, Elodie
Vassal, Olivia
Conrad, Anne
Ferry, Tristan
Millet, Aurelien
Dupont, Damien
Grandjean, Lola
Guitton, Jerome
Roux, Sandrine
Bienvenu, Anne-Lise
Bohe, Julien
Friggeri, Arnaud
Goutelle, Sylvain
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024,

← 1 2 3 4 5 →